We are live on ! Find out more
MYOV

Myovant Sciences Ltd.

Delisted

MYOV was delisted on the 9th of March, 2023.

96 hedge funds and large institutions have $676M invested in Myovant Sciences Ltd. in 2020 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more capital invested

Capital invested by funds: $253M → $676M (+$423M)

162% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 13

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

28% more funds holding

Funds holding: 7596 (+21)

15% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 26

28% less call options, than puts

Call options by funds: $5.97M | Put options by funds: $8.28M

Holders
96
Holders Change
+21
Holders Change %
+28%
% of All Funds
1.97%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
34
Increased
30
Reduced
26
Closed
13
Calls
$5.97M
Puts
$8.28M
Net Calls
-$2.31M
Net Calls Change
-$424K

MYOV Hedge Fund Activity: Q2 2020 in Review

96 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q2 2020, worth a combined $676M — up 167% from $253M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new MYOV positions and 13 closed out — a net gain of 21 holders — while 30 added to existing stakes and 26 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $30.3M. The largest seller was Victory Capital Management, cutting an estimated $40.5M.

  • 96 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q2 2020, up from 75 in Q1 2020.
  • Funds reported $676M of Myovant Sciences Ltd. stock for Q2 2020, up 167% quarter-over-quarter.
  • 34 funds opened new Myovant Sciences Ltd. positions in Q2 2020 and 13 closed out, a net change of +21 holders.
  • The largest Myovant Sciences Ltd. buyer in Q2 2020 was Fidelity Investments, an estimated $30.3M added.
  • The largest Myovant Sciences Ltd. seller in Q2 2020 was Victory Capital Management, an estimated $40.5M sold.

Based on aggregated 13F filings for Q2 2020.